Provided are novel compounds of Formula (I):
and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with potassium channels. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with potassium channels.
ANTIVIRAL COMPOUNDS AND METHOD FOR TREATING HEPATOTROPIC VIRAL INFECTION, PARTICULARLY HEPATITIS B AND HEPATITIS D
申请人:SENHWA BIOSCIENCES, INC.
公开号:US20210308137A1
公开(公告)日:2021-10-07
The present invention provides a compound or a method for treating a hepatotropic viral infection in a human, particularly hepatitis B and hepatitis D, wherein the compound is a certain tricyclic compound.
Chemoselective nitro reduction and hydroamination using a single iron catalyst
作者:Kailong Zhu、Michael P. Shaver、Stephen P. Thomas
DOI:10.1039/c5sc04471e
日期:——
The reduction and reductive addition (formal hydroamination) of functionalised nitroarenes is reported using a simple and bench-stable iron(III) catalyst and silane. The reduction is chemoselective for nitro groups over an array of reactive functionalities (ketone, ester, amide, nitrile, sulfonyl and aryl halide). The high activity of this earth-abundant metal catalyst also facilitates a follow-on